此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream

2011年6月13日 更新者:Loreal USA

Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF 40 Sunscreen Cream With Micronized TiO2 and Anthelios SX SPF 40 Cream (With Pigmentary TiO2) Into the Stratum Corneum of Compromised (Induced Sunburn) Human Skin

To determine the penetration of micronized and pigmentary TiO2 in Formulas 283419 2 and 760.001 into the stratum corneum of Compromised (Induced Sunburn) human skin via skin stripping of human subjects.

研究概览

地位

完全的

条件

研究类型

介入性

注册 (实际的)

26

阶段

  • 第四阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Manitoba
      • Winnipeg、Manitoba、加拿大、R3L2W2
        • Hill Top Research

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 65年 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • All subjects must:

    1. be between the ages of 18 and 65.
    2. agree to not participate in any other product evaluations or clinical evaluations during the course of this study.
    3. have read, understood and signed an Informed Consent Form.
    4. have intact skin in the treatment area.
    5. have fair skin - Skin Types I, or II - as defined in Appendix II.
    6. be able to understand and willing to follow all study procedures and restrictions.

Exclusion Criteria:

Subjects will be excluded from participating in the study if they:

  1. are female and are pregnant or lactating [must be using an acceptable method of birth control if of child bearing potential].*
  2. exhibit any visible symptoms of skin disease, such as psoriasis or eczema, or skin abnormality (including active dermal lesions, uneven skin tone or scars) which might interfere with interpretation of the study results. The presence of nevi, blemishes, or moles will be acceptable if, in the Investigator's judgement, they will not interfere with the study results or skin stripping procedures.
  3. have a history of allergic responses to sunscreens or other products similar to those included in this study.
  4. have very dry or scaly skin on the test site.
  5. have diabetes.
  6. have a history of abnormal responses to sunlight, such as a phototoxic or photoallergic response.
  7. have an existing sunburn or suntan, or been to a tanning booth which would interfere with interpretation of the study results.
  8. have used self tanners within the past two weeks.
  9. have excessive hair at the test site area which could, in the opinion of the investigator, interfere with the interpretation of the results.
  10. have participated in a research drug trial or patch test within six weeks of beginning this study.
  11. have a known sensitivity to Scotch 600 Transparent Tape.
  12. are currently receiving, or within the past two weeks received, topical or systemic medication which could, in the opinion of the investigator, interfere with the interpretation of the results, affect the safety of the subject, or which may change the body's response to ultraviolet light.
  13. are currently taking any of the drugs listed on the next page. In addition, the use of St. John's Wort or other similar dietary supplements, aspirin or OTC ibuprofen is contraindicated for the duration of the study. Low dose daily aspirin use, 81 mgs, taken for heart attack prevention is excluded.

    • Acceptable methods of birth control that can be used during the course of the study are: oral contraceptive pill, intrauterine device, patch, injection, condom with spermicide, partner vasectomy, bilateral tubal ligation, abstinence or evidence of non childbearing potential (i.e., post-menopausal [one year without menstrual period], hysterectomy or bilateral ovariectomy).

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 分配:随机化
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Determine degree of penetration of TiO2 down to 16 -20 tape strips of human skin
大体时间:Single application
Single application

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2009年12月1日

初级完成 (实际的)

2009年12月1日

研究完成 (实际的)

2009年12月1日

研究注册日期

首次提交

2009年11月25日

首先提交符合 QC 标准的

2009年11月27日

首次发布 (估计)

2009年11月30日

研究记录更新

最后更新发布 (估计)

2011年6月14日

上次提交的符合 QC 标准的更新

2011年6月13日

最后验证

2009年11月1日

更多信息

与本研究相关的术语

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

Titanium dioxide的临床试验

3
订阅